Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003554945 | SCV004292622 | pathogenic | not provided | 2024-08-31 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg492*) in the EIF2AK3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EIF2AK3 are known to be pathogenic (PMID: 11997520). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Wolcott-Rallison syndrome (PMID: 22672868). This variant is also known as c.1471C>T (p.Arg491X). For these reasons, this variant has been classified as Pathogenic. |